ResMed Inc (RSMDF) stock
RSMDFOTCSurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RMD
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 13, 2026Score 21/3011% below fair value
$22.61+0.00 (0.00%)
Close on Oct 19, 2026Market cap $33.17BP/E 22.0Yield 1.04%
ResMed gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
ResMed's gross profit for the twelve months ending Jun 30, 2026 was $3.45B, up 13.0% year over year. For fiscal 2026 it was $3.45B, up 13.0% from the year before. Over ten years it grew 12.5% a year on average. The highest annual figure on record is $3.45B in fiscal 2026.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $3.45B | +13.0% |
| FY2025 | Jun 30, 2025 | $3.05B | +15.1% |
| FY2024 | Jun 30, 2024 | $2.66B | +12.7% |
| FY2023 | Jun 30, 2023 | $2.36B | +16.4% |
| FY2022 | Jun 30, 2022 | $2.02B | +10.1% |
| FY2021 | Jun 30, 2021 | $1.84B | +7.1% |
| FY2020 | Jun 30, 2020 | $1.72B | +15.0% |
| FY2019 | Jun 30, 2019 | $1.49B | +11.9% |
| FY2018 | Jun 30, 2018 | $1.33B | +11.1% |
| FY2017 | Jun 30, 2017 | $1.20B | +12.7% |
| FY2016 | Jun 30, 2016 | $1.07B | +5.4% |
| FY2015 | Jun 30, 2015 | $1.01B | +2.2% |
| FY2014 | Jun 30, 2014 | $989.79M | +5.2% |
| FY2013 | Jun 30, 2013 | $940.66M | +14.6% |
| FY2012 | Jun 30, 2012 | $820.74M | +10.7% |
| FY2011 | Jun 30, 2011 | $741.33M | +13.1% |
| FY2010 | Jun 30, 2010 | $655.48M | +18.4% |
| FY2009 | Jun 30, 2009 | $553.80M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026 | Jun 30, 2026 | $861.22M | +5.0% |
| Q3 FY2026 | Mar 31, 2026 | $890.98M | +16.3% |
| Q2 FY2026 | Dec 31, 2025 | $878.72M | +17.0% |
| Q1 FY2026 | Sep 30, 2025 | $820.82M | +14.4% |
| Q4 FY2025 | Jun 30, 2025 | $820.07M | +14.6% |
| Q3 FY2025 | Mar 31, 2025 | $766.41M | +10.6% |
| Q2 FY2025 | Dec 31, 2024 | $751.28M | +16.1% |
| Q1 FY2025 | Sep 30, 2024 | $717.22M | +19.5% |
| Q4 FY2024 | Jun 30, 2024 | $715.53M | +15.9% |
| Q3 FY2024 | Mar 31, 2024 | $692.78M | +12.1% |
| Q2 FY2024 | Dec 31, 2023 | $646.93M | +11.6% |
| Q1 FY2024 | Sep 30, 2023 | $600.06M | +11.0% |
| Q4 FY2023 | Jun 30, 2023 | $617.39M | +18.2% |
| Q3 FY2023 | Mar 31, 2023 | $617.75M | +25.8% |
| Q2 FY2023 | Dec 31, 2022 | $579.72M | +15.0% |
| Q1 FY2023 | Sep 30, 2022 | $540.81M | +6.8% |
| Q4 FY2022 | Jun 30, 2022 | $522.51M | +6.5% |
| Q3 FY2022 | Mar 31, 2022 | $491.20M | +9.8% |
| Q2 FY2022 | Dec 31, 2021 | $504.32M | +9.0% |
| Q1 FY2022 | Sep 30, 2021 | $506.29M | +15.4% |
| Q4 FY2021 | Jun 30, 2021 | $490.70M | +9.2% |
| Q3 FY2021 | Mar 31, 2021 | $447.26M | -0.5% |
| Q2 FY2021 | Dec 31, 2020 | $462.48M | +8.3% |
| Q1 FY2021 | Sep 30, 2020 | $438.66M | +12.0% |
| Q4 FY2020 | Jun 30, 2020 | $449.37M | +11.7% |
| Q3 FY2020 | Mar 31, 2020 | $449.66M | +18.0% |
| Q2 FY2020 | Dec 31, 2019 | $427.13M | +14.0% |
| Q1 FY2020 | Sep 30, 2019 | $391.62M | +14.1% |
| Q4 FY2019 | Jun 30, 2019 | $402.43M | +20.1% |
| Q3 FY2019 | Mar 31, 2019 | $380.97M | +10.7% |
| Q2 FY2019 | Dec 31, 2018 | $374.53M | +7.1% |
| Q1 FY2019 | Sep 30, 2018 | $343.09M | +12.3% |
| Q4 FY2018 | Jun 30, 2018 | $335.21M | +3.5% |
| Q3 FY2018 | Mar 31, 2018 | $344.30M | +14.9% |
| Q2 FY2018 | Dec 31, 2017 | $349.79M | +13.2% |
| Q1 FY2018 | Sep 30, 2017 | $305.61M | +13.5% |
| Q4 FY2017 | Jun 30, 2017 | $323.78M | – |
| Q3 FY2017 | Mar 31, 2017 | $299.71M | – |
| Q2 FY2017 | Dec 31, 2016 | $309.07M | – |
| Q1 FY2017 | Sep 30, 2016 | $269.18M | – |